Tovey Crutchfield, Emma C.
Garnish, Sarah E.
Day, Jessica
Anderton, Holly https://orcid.org/0000-0003-3913-9686
Chiou, Shene
Hempel, Anne
Hall, Cathrine
Patel, Komal M.
Gangatirkar, Pradnya
Martin, Katherine R. https://orcid.org/0000-0001-9453-9573
Li Wai Suen, Connie S. N. https://orcid.org/0000-0003-0529-0804
Garnham, Alexandra L.
Kueh, Andrew J.
Wicks, Ian P. https://orcid.org/0000-0001-7050-6822
Silke, John https://orcid.org/0000-0002-7611-5774
Nachbur, Ueli
Samson, Andre L. https://orcid.org/0000-0002-0637-2716
Murphy, James M. https://orcid.org/0000-0003-0195-3949
Hildebrand, Joanne M. https://orcid.org/0000-0002-1456-2042
Funding for this research was provided by:
Arthritis Australia (Project grant)
Department of Health | National Health and Medical Research Council (1154325)
Department of Health | National Health and Medical Research Council (1113577)
Department of Health | National Health and Medical Research Council (1195038)
Department of Health | National Health and Medical Research Council (2002965)
Department of Health | National Health and Medical Research Council (1172929)
Department of Health | National Health and Medical Research Council (9000719)
Department of Health | National Health and Medical Research Council (1142669)
Department of Health | National Health and Medical Research Council (2011584)
Article History
Received: 12 October 2022
Revised: 16 January 2023
Accepted: 23 January 2023
First Online: 8 February 2023
Competing interests
: SEG, AH, KMP, PG, IPW, JS, UN, ALS, JMM and JMH contribute to or have contributed to a project developing necroptosis inhibitors in collaboration with Anaxis Pharma. The other authors declare no competing interests.
: All experiments were approved by the WEHI Animal Ethics Committee following the Prevention of Cruelty to Animals Act (1996) and the Australian National Health and Medical Research Council Code of Practice for the Care and Use of Animals for Scientific Purposes (1997).